Evofem Biosciences, Inc. (EVFM)
0.0071
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Evofem Biosciences Shareholders Equity (Quarterly) : -82.49M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -82.49M |
| March 31, 2026 | -72.71M |
| December 31, 2025 | -69.44M |
| September 30, 2025 | -70.17M |
| June 30, 2025 | -64.83M |
| March 31, 2025 | -64.80M |
| December 31, 2024 | -66.48M |
| September 30, 2024 | -66.13M |
| June 30, 2024 | -64.63M |
| March 31, 2024 | -66.03M |
| December 31, 2023 | -61.92M |
| September 30, 2023 | -54.56M |
| June 30, 2023 | -55.66M |
| March 31, 2023 | -56.40M |
| December 31, 2022 | -71.80M |
| September 30, 2022 | -78.04M |
| June 30, 2022 | -216.00M |
| March 31, 2022 | -123.96M |
| December 31, 2021 | -99.58M |
| September 30, 2021 | -58.83M |
| June 30, 2021 | 8.964M |
| March 31, 2021 | -13.64M |
| December 31, 2020 | 1.347M |
| September 30, 2020 | 40.21M |
| June 30, 2020 | 68.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.021M |
| December 31, 2019 | 15.64M |
| September 30, 2019 | 24.08M |
| June 30, 2019 | 35.79M |
| March 31, 2019 | -28.85M |
| December 31, 2018 | -23.36M |
| September 30, 2018 | -10.06M |
| June 30, 2018 | 5.258M |
| March 31, 2018 | -18.29M |
| December 31, 2017 | -99.68M |
| September 30, 2017 | 4.850M |
| June 30, 2017 | 6.513M |
| March 31, 2017 | 9.035M |
| December 31, 2016 | 11.91M |
| September 30, 2016 | 13.77M |
| June 30, 2016 | 16.04M |
| March 31, 2016 | 18.50M |
| December 31, 2015 | 23.81M |
| September 30, 2015 | 32.73M |
| June 30, 2015 | 49.58M |
| March 31, 2015 | 58.64M |
| December 31, 2014 | 65.25M |
| September 30, 2014 | 6.707M |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.522M |
| Total Liabilities (Quarterly) | 90.01M |
| Debt to Equity Ratio | -0.6586 |
| Current Ratio | 0.0686 |
| Net Debt Paydown Yield | -162.8% |